HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bela F Asztalos Selected Research

Niacin (Nicotinic Acid)

9/2010High-density lipoprotein particles, coronary heart disease, and niacin.
9/2008Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
5/2003Change in alpha1 HDL concentration predicts progression in coronary artery stenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bela F Asztalos Research Topics

Disease

29Coronary Disease (Coronary Heart Disease)
01/2022 - 10/2002
19Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2005
12Coronary Artery Disease (Coronary Atherosclerosis)
04/2016 - 04/2003
9Inflammation (Inflammations)
11/2022 - 07/2004
9Atherosclerosis
04/2016 - 05/2003
5Stroke (Strokes)
01/2019 - 03/2003
5Hypertriglyceridemia
10/2016 - 08/2008
5Tangier Disease
09/2016 - 04/2003
4Hypertension (High Blood Pressure)
01/2021 - 08/2011
4Obesity
03/2019 - 10/2004
4Myocardial Infarction
01/2019 - 10/2005
4Insulin Resistance
03/2017 - 06/2011
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2022 - 10/2004
3Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
09/2016 - 11/2011
3Hyperlipidemias (Hyperlipidemia)
05/2015 - 09/2008
3HIV Infections (HIV Infection)
06/2014 - 01/2006
3Type 2 Diabetes Mellitus (MODY)
01/2014 - 08/2009
3Xanthomatosis (Xanthoma)
08/2010 - 02/2008
3Heart Diseases (Heart Disease)
12/2007 - 08/2006
2Dyslipidemias (Dyslipidemia)
09/2015 - 08/2010
2Arcus Senilis
08/2014 - 02/2008
2Anemia
03/2014 - 11/2011
2Renal Insufficiency (Renal Failure)
03/2014 - 11/2011
2Corneal Opacity
03/2014 - 11/2009
2Hypercholesterolemia
08/2011 - 05/2005
1Diabetes Mellitus
01/2021
1Overweight
03/2019
1Lipase deficiency combined
10/2016
1Stable Angina
04/2016
1Fibrosis (Cirrhosis)
09/2015
1Hyperlipoproteinemia Type III (Broad Beta Disease)
10/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2014
1Splenomegaly
03/2014
1Atherosclerotic Plaque (Atheroma)
01/2014
1Endotoxemia
06/2012

Drug/Important Bio-Agent (IBA)

26HDL LipoproteinsIBA
12/2019 - 10/2002
25CholesterolIBA
11/2022 - 07/2004
25HDL CholesterolIBA
01/2021 - 03/2003
20Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2018 - 10/2002
13Lipoproteins (Lipoprotein)IBA
11/2022 - 10/2002
12LipidsIBA
11/2022 - 10/2002
11oxidized low density lipoproteinIBA
01/2021 - 06/2008
10LDL CholesterolIBA
01/2021 - 03/2003
10ApolipoproteinsIBA
09/2016 - 10/2002
9LDL Lipoproteins (beta Lipoproteins)IBA
01/2021 - 04/2003
7Triglycerides (Triacylglycerol)IBA
01/2021 - 03/2008
7Atorvastatin (Lipitor)FDA Link
02/2011 - 10/2002
6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2014 - 10/2002
5Adenosine Triphosphate (ATP)IBA
01/2022 - 08/2008
5C-Reactive ProteinIBA
01/2019 - 05/2005
5Cholesterol Esters (Cholesteryl Esters)IBA
09/2016 - 08/2006
5Apolipoproteins E (ApoE)IBA
10/2014 - 03/2004
4Cholesterol Ester Transfer ProteinsIBA
11/2022 - 03/2004
4Glucose (Dextrose)FDA LinkGeneric
04/2016 - 08/2010
4Apolipoproteins AIBA
08/2014 - 03/2004
4Proteins (Proteins, Gene)FDA Link
06/2014 - 08/2008
3lipoprotein cholesterolIBA
01/2021 - 07/2009
3Apolipoprotein B-100 (Apo B 100)IBA
05/2015 - 10/2004
3Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA
06/2014 - 08/2008
3Niacin (Nicotinic Acid)FDA LinkGeneric
09/2010 - 05/2003
3Apolipoprotein A-II (Apolipoprotein A2)IBA
09/2008 - 03/2004
3Lovastatin (Mevacor)FDA LinkGeneric
09/2008 - 10/2002
3torcetrapibIBA
12/2007 - 05/2005
3Simvastatin (Zocor)FDA LinkGeneric
05/2005 - 10/2002
2TransferasesIBA
11/2022 - 09/2016
2LecithinsIBA
11/2022 - 09/2016
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
11/2022 - 10/2016
2Scavenger Receptors (Scavenger Receptor)IBA
01/2022 - 01/2018
2AdiponectinIBA
10/2020 - 08/2011
2Insulin (Novolin)FDA Link
03/2017 - 11/2016
2Eicosapentaenoic AcidIBA
11/2016 - 08/2015
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2016 - 08/2014
2Docosahexaenoic AcidsIBA
11/2016 - 08/2015
2Phosphatidylcholines (Phosphatidylcholine)IBA
04/2016 - 01/2014
2MDCO-216IBA
04/2016 - 01/2014
2Rosuvastatin Calcium (Crestor)FDA Link
05/2015 - 02/2011
2Leucine (L-Leucine)FDA Link
03/2013 - 10/2004
2Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
12/2010 - 07/2009
2Conjugated (USP) Estrogens (Premarin)FDA Link
12/2010 - 07/2009
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
06/2008 - 05/2005
2Gemfibrozil (Lopid)FDA LinkGeneric
01/2008 - 03/2003
2FluvastatinFDA Link
05/2005 - 10/2002
2Pravastatin (Pravachol)FDA LinkGeneric
05/2005 - 10/2002
1EstersIBA
11/2022
1eicosapentaenoic acid ethyl esterIBA
11/2022
1Lipoprotein(a)IBA
01/2021
1Fish OilsIBA
11/2016
1Lipase (Acid Lipase)FDA Link
10/2016
1AcyltransferasesIBA
09/2016
1Apoprotein(a) (Apolipoprotein (a))IBA
04/2016
1Fenofibrate (CiL)FDA LinkGeneric
04/2016
1DNA (Deoxyribonucleic Acid)IBA
09/2015
1Nonsense Codon (Nonsense Mutation)IBA
08/2014
1LDL Receptors (LDL Receptor)IBA
03/2014
1polyacrylamideIBA
01/2014
1ATP Binding Cassette Transporter 1IBA
01/2013
1Member 1 Subfamily G ATP Binding Cassette TransporterIBA
06/2012

Therapy/Procedure

7Therapeutics
06/2015 - 01/2006
2Estrogen Replacement Therapy
12/2010 - 07/2009
1Polypharmacy
06/2015